|
Placentation
|
D010929 |
[The development of the PLACENTA, a highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products between mother and FETUS. The process begins at FERTILIZATION, through the development of CYTOTROPHOBLASTS and SYNCYTIOTROPHOBLASTS, the formation of CHORIONIC VILLI, to the progressive increase in BLOOD VESSELS to support the growing fetus.
] |
|
Water Movements
|
N06.230.132.644.750 |
|
|
Organic Chemicals
|
D009930 |
[A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form.
] |
|
Methylobacteriaceae
|
B03.440.400.425.487 |
|
|
Placenta
|
D010920 |
[A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES).
] |
|
Somatosensory Cortex
|
A08.186.211.200.885.287.500.670.675 |
|
|
Placenta Accreta
|
D010921 |
[Invasion of CHORIONIC VILLI occurs through the MYOMETRIUM penetrating the uterine SEROSA.
, Invasion of CHORIONIC VILLI occurs deep into the MYOMETRIUM.
, Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.
] |
|
Placenta Diseases
|
D010922 |
[Pathological processes or abnormal functions of the PLACENTA.
] |
|
Placenta Previa
|
D010923 |
[Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS (the zone of dilation) and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.
] |
|
Cohort Effect
|
N05.715.350.350.225 |
|
|
Effect Modifier, Epidemiologic
|
N05.715.350.350 |
|
|
Nesidioblastosis
|
C18.452.394.984.200.500 |
|
|
Congenital Hyperinsulinism
|
C18.452.394.984.200 |
|
|
Manufacturing Industry
|
J01.576.655 |
|
|
Nuclear Reactors
|
E07.710.600 |
|
|
Glafenine
|
D02.455.426.559.389.127.020.906.875 |
|
|
Leptothrix
|
B03.440.400.425.481 |
|
|
Magnesium Hydroxide
|
D01.045.250.575 |
|
|
Androstenes
|
D04.210.500.054.079 |
|
|
Androstanes
|
D04.210.500.054 |
|
